Clinical Trail of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Upper Limb Bradykinesia in Parkinson' Disease' Patients
Launched by XINHUA HOSPITAL, SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE · Oct 11, 2024
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hoehn and Yahr (HY) stage 1-2
- • Able to understand and cooperate with the study
- • Predominantly characterized by bradykinesia
- • Onset on the left side
- Exclusion Criteria:
- • Contraindications for TMS including DBS surgery, Ventriculoperitoneal shunt, etc
- • Other neurological disorders
- • Significant resting tremor, with MDS-UPDRS-III tremor score ≥3
- • Resting threshold cannot be measured
- • Received other TMS treatments within the last 3 months
About Xinhua Hospital, Shanghai Jiao Tong University School Of Medicine
Xinhua Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a prominent clinical research institution renowned for its commitment to advancing medical science and patient care. Located in Shanghai, China, the hospital integrates clinical practice, education, and research, fostering innovation in various medical fields. With state-of-the-art facilities and a multidisciplinary team of experts, Xinhua Hospital conducts rigorous clinical trials aimed at evaluating new therapies and improving treatment outcomes. Its dedication to ethical standards and patient safety positions it as a leader in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shanghai, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported